Journal
EUROPEAN HEART JOURNAL
Volume 32, Issue 11, Pages 1369-1378Publisher
OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehr029
Keywords
blood flow; endocannabinoids; circulation; coronary disease; endothelium; obesity
Categories
Funding
- Swiss National Science Foundation (SNF) [3200B0-122237]
- Clinical Research Center, University Hospital and Faculty of Medicine, Geneva
- Louis-Jeantet Foundation, Swiss Heart Foundation
- Department of Internal Medicine of the University Hospitals of Geneva (Switzerland)
- Novartis Foundation
- European Society of Cardiology (ESC)
- Italian Society of Cardiology (Societa' Italiana di Cardiologia
- SIC)
Ask authors/readers for more resources
Aims Aim of this study was to evaluate a possible association between endocannabinoid (EC) plasma levels, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and coronary circulatory function in obesity. Methods and results Myocardial blood flow (MBF) responses to cold pressor test (CPT) and during pharmacological vasodilation with dipyridamole were measured with (13)N-ammonia PET/CT. Study participants (n = 77) were divided into three groups based on their body mass index (BMI, kg/m(2)): control group 20 <= BMI <= 25 (n = 21); overweight group, 25 <= BMI <30 (n = 26); and obese group, BMI >= 30 (n = 30). Anandamide plasma levels, but not 2-AG plasma levels, were significantly elevated in obesity as compared with controls, respectively [0.68 (0.53, 0.78) vs. 0.56 (0.47, 0.66) ng/mL, P = 0.020, and 2.2 (1.21, 4.59) vs. 2.0 (0.80, 5.90) ng/mL, P = 0.806)]. The endothelium-related change in MBF during CPT from rest (Delta MBF) progressively declined in overweight and obese when compared with control group [0.21 (0.10, 0.27) and 0.09 (-0.01, 0.15) vs. 0.26 (0.23, 0.39) mL/g/min; P = 0.010 and P = 0.0001, respectively). Compared with controls, hyperaemic MBFs were significantly lower in overweight and obese individuals [2.39 (1.97, 2.62) vs. 1.98 (1.69, 2.26) and 2.10 (1.76, 2.36); P = 0.007 and P = 0.042, respectively)]. In obese individuals, AEA and 2-AG plasma levels were inversely correlated with Delta MBF to CPT (r = -0.37, P = 0.046 and r = -0.48, P = 0.008) and hyperaemic MBFs (r = -0.38, P = 0.052 and r = -0.45, P = 0.017), respectively. Conclusions Increased EC plasma levels of AEA and 2-AG are associated with coronary circulatory dysfunction in obese individuals. This observation might suggest increases in EC plasma levels as a novel endogenous cardiovascular risk factor in obesity, but needing further investigations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available